This is a randomized clinical trial evaluating blue light 5-aminolevulinic acid (ALA) photodynamic therapy with different incubation times for the treatment of actinic keratosis. Subjects who are interested in participating, currently living in the Chicago metropolitan area, and meet inclusion and exclusion criteria will be enrolled in the study. Subjects will be randomized to either 1) zero time ALA incubation or 2) 1 hour ALA incubation. Demographic and health data will be collected prior to treatment initiation. Three visits will be conducted: screening, treatment, and follow up visit at 8 weeks. This study is a pilot study designed to determine feasibility of this procedure.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
28
ALA (5-aminolevulinic acid) will be applied to subjects' skin for either zero time incubation or one hour incubation
Subjects will be exposed to blue light
Northwestern University Feinberg School of Medicine, Department of Dermatology
Chicago, Illinois, United States
Change in number of Actinic Keratosis (AK) lesions
The number of AK lesions will be counted by a live, blinded assessor at baseline and at Week 8 follow-up visit.
Time frame: Baseline and 8 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.